ArticleNature medicine2012
Reply to: Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib.
Article in Nature medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 50 citations in OpenAlex.
- Histological assessment for investigation of dose-dependent ovarian toxicity of cyclophosphamide in the rat.Heliyon · 2024Article
- The future of fertility preservation for women treated with chemotherapy.Reproduction & fertility · 2023Article
- Potential ovarian toxicity and infertility risk following targeted anti-cancer therapies.Reproduction & fertility · 2022Review
- Can Some Anticancer Treatments Preserve the Ovarian Reserve?The oncologist · 2021Review
- Asciminib Mitigates DNA Damage Stress Signaling Induced by Cyclophosphamide in the Ovary.International journal of molecular sciences · 2021Article
- State of the Art in Fertility Preservation for Female Patients Prior to Oncologic Therapies.Medicina (Kaunas, Lithuania) · 2020Review
- Ovarian damage from chemotherapy and current approaches to its protection.Human reproduction update · 2019Review
- The Impact of Chemotherapy on the Ovaries: Molecular Aspects and the Prevention of Ovarian Damage.International journal of molecular sciences · 2019Review
- Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertility.Cell death & disease · 2019Article
- Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapies.Cell death and differentiation · 2019Article
- Fertility Preservation in Women With Malignancy: Future Endeavors.Clinical medicine insights. Reproductive health · 2019Review
- Pharmacological Inhibition of the DNA Damage Checkpoint Prevents Radiation-Induced Oocyte Death.Genetics · 2017Article
- Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy.International journal of molecular sciences · 2017Review
- LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse.Cell death and differentiation · 2017Article
- Culture and co-culture of mouse ovaries and ovarian follicles.Journal of visualized experiments : JoVE · 2015Article
- Oocyte-specific inactivation of Omcg1 leads to DNA damage and c-Abl/TAp63-dependent oocyte death associated with dramatic remodeling of ovarian somatic cells.Cell death and differentiation · 2015Article
- Docetaxel induces moderate ovarian toxicity in mice, primarily affecting granulosa cells of early growing follicles.Molecular human reproduction · 2014Article
- Defying DNA double-strand break-induced death during prophase I meiosis by temporal TAp63α phosphorylation regulation in developing mouse oocytes.Molecular and cellular biology · 2014Article
- Defying c-Abl signaling circuits through small allosteric compounds.Frontiers in genetics · 2014Article
- Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network.Cell death and differentiation · 2013Article
Corrections and comments
- Comment on
Authors and funding
12 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.